Sage Rhino Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-464
| Closed | -$202K | – | 285 |
|
2025
Q1 | $202K | Buy |
+464
| New | +$202K | 0.05% | 239 |
|
2024
Q4 | – | Sell |
-482
| Closed | -$251K | – | 278 |
|
2024
Q3 | $251K | Hold |
482
| – | – | 0.06% | 200 |
|
2024
Q2 | $261K | Buy |
482
+8
| +2% | +$4.34K | 0.06% | 185 |
|
2024
Q1 | $246K | Buy |
474
+21
| +5% | +$10.9K | 0.06% | 189 |
|
2023
Q4 | $214K | Buy |
+453
| New | +$214K | 0.05% | 197 |
|
2023
Q3 | – | Sell |
-452
| Closed | -$201K | – | 226 |
|
2023
Q2 | $201K | Sell |
452
-3
| -0.7% | -$1.33K | 0.06% | 202 |
|
2023
Q1 | $209K | Sell |
455
-3
| -0.7% | -$1.38K | 0.06% | 197 |
|
2022
Q4 | $235K | Hold |
458
| – | – | 0.07% | 182 |
|
2022
Q3 | $208K | Sell |
458
-1
| -0.2% | -$454 | 0.08% | 165 |
|
2022
Q2 | $222K | Buy |
459
+1
| +0.2% | +$484 | 0.08% | 170 |
|
2022
Q1 | $225K | Hold |
458
| – | – | 0.07% | 192 |
|
2021
Q4 | $212K | Buy |
+458
| New | +$212K | 0.06% | 203 |
|